Groowe Groowe / Newsroom / SNY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

SNY News

Sanofi American Depositary Shares (Each representing one-half of one ordinary share)

Earendil Labs Announces Strategic Collaboration with Sanofi to Discover Bispecific Antibodies for Autoimmune Diseases

prnewswire.com
SNY

Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies Corporation - DVAX

prnewswire.com
DVAX SNY

The Skin of Color Society (SOCS) Reports an Impactful Year of Progress, Expansion, and Innovation Toward Advancing Knowledge and Excellence in Patient Care

prnewswire.com
JNJ LLY SNY REGN ABBV AERO BIIB GALT TAK ELMD PFE SUN INCY BMY ARQT UCB

Insilico Medicine Lists on Hong Kong Stock Exchange, Showing AI Drug Discovery Momentum with 2025's Largest Hong Kong Biotech IPO

prnewswire.com
EXEL SNY

Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies Corporation - DVAX

businesswire.com
DVAX SNY

CORRECTING and REPLACING Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies Corporation - DVAX

businesswire.com
DVAX SNY

Honoring 45 Organ, Eye and Tissue Donors, Living Donors and Recipients: The 2026 OneLegacy Donate Life Rose Parade® Float Celebrates 23 Years of Participation in the Iconic Rose Parade®

businesswire.com
SNY

Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline

globenewswire.com
SNY DVAX

Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis

globenewswire.com
SNY

Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia

globenewswire.com
SNY